Group A: CHD or stroke | n | Percentage of 5193 | n | Percentage of 5784 | Relative percentage change | Absolute percentage change | P-value for changea |
Lipid lowering drugs | 1596 | 30.7 | 2335 | 40.4 | 31.4 | 9.6 | 0.002 |
Last FSC >5 mmol/l | 1361 | 26.2 | 1854 | 32.1 | 22.3 | 5.8 | <0.0001 |
Obesity | 929 | 17.9 | 1146 | 19.8 | 10.8 | 1.9 | 0.030 |
Current smoker | 937 | 18.0 | 797 | 13.8 | −23.6 | −4.3 | |
BP <140/85 mmHg | 2288 | 44.1 | 2940 | 50.8 | 15.4 | 6.8 | 0.002 |
BP <160/90 mmHg | 3987 | 76.8 | 4652 | 80.4 | 4.8 | 3.7 | 0.018 |
Had MI but not on β-blockersb | 559 | 40.6 | 547 | 34.5 | −14.9 | −6.1 | 0.240 |
On aspirin | 3880 | 74.7 | 4583 | 79.2 | 6.0 | 4.5 | 0.004 |
Not on aspirin, and no contraindications | 1015 | 19.5 | 919 | 15.9 | −18.7 | −3.7 | 0.005 |
|
Group B: diabetes or hypertension | n | Percentage of 7288 | n | Percentage of 8374 | Relative percentage change | Absolute percentage change | P-value for changea |
|
Lipid lowering drugs | 465 | 6.4 | 748 | 8.9 | 40.0 | 2.6 | <0.001 |
Last FSC >5 mmol/l | 1929 | 26.5 | 3235 | 38.6 | 46.0 | 12.2 | 0.741 |
Obesity | 1764 | 24.2 | 2182 | 26.1 | 7.7 | 1.9 | 0.042 |
Current smoker | 1254 | 17.3 | 1120 | 13.4 | −22.3 | −3.8 | |
BP <140/85 mmHg | 1840 | 25.2 | 2638 | 31.5 | 24.8 | 6.3 | 0.001 |
BP <160/90 mmHg | 4684 | 64.3 | 5940 | 70.9 | 10.4 | 6.7 | 0.003 |
On aspirin | 2355 | 32.3 | 2904 | 34.7 | 7.3 | 2.4 | 0.093 |
|
Group C: remaining population | n | Percentage of 42 086 | Percentage of 42 827 | Relative percentage change | Absolute percentage change | P-value for changea |
|
Lipid lowering drugs | 398 | 0.9 | 422 | 1.0 | 4.2 | 0.0 | 0.669 |
Last FSC >5 mmol/l | 3169 | 7.5 | 4259 | 9.9 | 32.1 | 2.4 | 0.242 |
Obesity | 4346 | 10.3 | 4878 | 11.4 | 10.3 | 1.1 | 0.013 |
Current smoker | 9388 | 22.3 | 7562 | 17.7 | −20.8 | −4.6 | |
BP <140/85 mmHg | 22 008 | 52.3 | 24 309 | 56.8 | 8.5 | 4.5 | 0.003 |
BP <160/90 mmHg | 30 807 | 73.2 | 33 075 | 77.2 | 5.5 | 4.0 | 0.008 |
On aspirin | 10 020 | 23.8 | 10 471 | 24.4 | 2.7 | 0.6 | 0.088 |